Filana Therapeutics (FLNA) Assets (2010 - 2026)

Filana Therapeutics has reported Assets for 17 years, with the latest figure at $103.9 million in Q2 2026.

• On a quarterly basis, Assets fell 23.25% year-over-year to $103.9 million in Q2 2026; TTM through Jun 2026 was $103.9 million, a 23.25% decrease from a year earlier, with the FY2025 full-year figure at $118.4 million, down 24.87% from the prior year.
• Assets was $103.9 million for Q2 2026 at Filana Therapeutics, down from $108.4 million in the prior quarter.
• The five-year high for Assets was $244.2 million in Q1 2022, with the low at $103.9 million in Q2 2026.
• Average Assets over 5 years is $176.1 million, with a median of $165.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Assets rose 29.69% in 2024, then plunged 44.42% in 2025.
• Over 5 years, Assets stood at $234.8 million in 2022, then slumped by 35.42% to $151.7 million in 2023, then climbed by 3.87% to $157.5 million in 2024, then fell by 24.87% to $118.4 million in 2025, then retreated by 12.21% to $103.9 million in 2026.
• The last three Assets figures came in at $103.9 million (Q2 2026), $108.4 million (Q1 2026), and $118.4 million (Q4 2025), per Business Quant data.